Saturday, May 25, 2013 8:21pm EDT
NBY - Novabay Pharmaceuticals, Inc. - Insider Transactions
SEC Form 4 |
Date |
Sym |
Company |
Insider |
Title |
Shares |
Transaction |
Value |
|---|---|---|---|---|---|---|---|---|
Dec 11 2012 | NBY | Novabay Pharmaceuticals, Inc. | Li Xinzhou | Pres.Naqu Area Pioneer Pharma, 10% Owner | 120,000 | Purchase at $1.20 | $144,000 | |
Oct 31 2012 | NBY | Novabay Pharmaceuticals, Inc. | Li Xinzhou | 10% Owner | 1,200,000 | Purchase at $1.25 | $1,500,000 | |
Sep 13 2012 | NBY | Novabay Pharmaceuticals, Inc. | Li Xinzhou | 10% Owner | 800,000 | Purchase at $1.25 | $1,000,000 | |
Dec 6 2012 | NBY | Novabay Pharmaceuticals, Inc. | Stroman David W. | SVP, Ophthalmic Product Devt. | 10,000 | Purchase at $1.24 | $12,400 | |
Dec 6 2012 | NBY | Novabay Pharmaceuticals, Inc. | Paulson Thomas J | CFO | 10,000 | Purchase at $1.24 | $12,400 | |
Dec 6 2012 | NBY | Novabay Pharmaceuticals, Inc. | Najafi Ramin | CEO, 10% Owner | 20,000 | Purchase at $1.24 | $24,800 | |
Oct 27 2012 | NBY | Novabay Pharmaceuticals, Inc. | Paulson Thomas J | CFO | 3,645 | Option payment at $1.31 | $4,775 | |
Oct 27 2012 | NBY | Novabay Pharmaceuticals, Inc. | Najafi Ramin | CEO, 10% Owner | 4,557 | Option payment at $1.31 | $5,970 | |
Oct 31 2012 | NBY | Novabay Pharmaceuticals, Inc. | Naqu Area Pioneer Pharma Co., Ltd. | 10% Owner | 1,200,000 | Purchase at $1.25 | $1,500,000 | |
Oct 31 2012 | NBY | Novabay Pharmaceuticals, Inc. | Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | 1,200,000 | Purchase at $1.25 | $1,500,000 | |
Sep 27 2012 | NBY | Novabay Pharmaceuticals, Inc. | Tufts Robert R. | Director | 28,500 | Option exercise at $0.56 | $15,960 | |
May 30 2012 | NBY | Novabay Pharmaceuticals, Inc. | Paulson Thomas J | CFO | 10,000 | Purchase at $0.94 | $9,364 | |
MMay 29 2012 | NBY | Novabay Pharmaceuticals, Inc. | Najafi Ramin | CEO | 6,000 | Purchase at $0.96 | $5,756 | |
May 25 2012 | NBY | Novabay Pharmaceuticals, Inc. | Najafi Ramin | CEO | 3,500 | Purchase at $0.99 | $3,465 | |
Dec 29 2011 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 30,000 | Option exercise at $0.20 | $6,000 | |
Oct 27 2011 | NBY | Novabay Pharmaceuticals, Inc. | Najafi Ramin | CEO | 50,000 | Grant at $1.09 | $54,500 | |
Oct 27 2011 | NBY | Novabay Pharmaceuticals, Inc. | Paulson Thomas J | CFO | 40,000 | Grant at $1.09 | $43,600 | |
Sep 29 2011 | NBY | Novabay Pharmaceuticals, Inc. | Najafi Ramin | CEO | 152,673 | Grant at $0.90 | $137,406 | |
Sep 12 2011 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 3,000 | Purchase at $0.84 | $2,520 | |
MAug 26 2011 | NBY | Novabay Pharmaceuticals, Inc. | Paulson Thomas J | CFO | 3,500 | Purchase at $0.86 | $3,010 | |
Aug 16 2011 | NBY | Novabay Pharmaceuticals, Inc. | Najafi Ramin | CEO | 10,000 | Purchase at $0.85 | $8,500 | |
Aug 15 2011 | NBY | Novabay Pharmaceuticals, Inc. | Tufts Robert R. | Director | 5,000 | Purchase at $0.85 | $4,242 | |
May 27 2011 | NBY | Novabay Pharmaceuticals, Inc. | Najafi Ramin | CEO | 500 | Purchase at $1.59 | $797 | |
MMay 27 2011 | NBY | Novabay Pharmaceuticals, Inc. | Khosrovi Behzad | VP Research, Development | 1,000 | Purchase at $1.64 | $1,644 | |
MMay 27 2011 | NBY | Novabay Pharmaceuticals, Inc. | McPherson T. Alex | Director | 6,200 | Purchase at $1.65 | $10,217 | |
MMay 26 2011 | NBY | Novabay Pharmaceuticals, Inc. | Najafi Ramin | CEO | 1,000 | Purchase at $1.60 | $1,597 | |
MMay 24 2011 | NBY | Novabay Pharmaceuticals, Inc. | Najafi Ramin | CEO | 2,552 | Purchase at $1.71 | $4,371 | |
Sep 2 2008 | NBY | Novabay Pharmaceuticals, Inc. | Najafi Ramin | CEO | 1,000 | Purchase at $1.98 | $1,980 | |
Jan 14 2009 | NBY | Novabay Pharmaceuticals, Inc. | Cashion Charles | Director | 8,239 | Grant at $0.00 | $0 | |
Jan 14 2009 | NBY | Novabay Pharmaceuticals, Inc. | McPherson T. Alex | Director | 9,084 | Grant at $0.00 | $0 | |
Aug 25 2008 | NBY | Novabay Pharmaceuticals, Inc. | Wicks Tony D.S. | Director | 1,353 | Grant at $0.00 | $0 | |
Aug 25 2008 | NBY | Novabay Pharmaceuticals, Inc. | Tufts Robert R. | Director | 1,353 | Grant at $0.00 | $0 | |
Aug 25 2008 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 1,353 | Grant at $0.00 | $0 | |
Aug 25 2008 | NBY | Novabay Pharmaceuticals, Inc. | Dailley Anthony | Director | 1,353 | Grant at $0.00 | $0 | |
Oct 6 2009 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 343 | Grant at $0.00 | $0 | |
Sep 14 2009 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 1,350 | Grant at $0.00 | $0 | |
Aug 28 2009 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 1,428 | Grant at $0.00 | $0 | |
Aug 16 2010 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 15,000 | Sale at $1.83 | $27,450 | |
Aug 28 2009 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 1,428 | Grant at $0.00 | $0 | |
Jan 4 2010 | NBY | Novabay Pharmaceuticals, Inc. | Tufts Robert R. | Director | 18,158 | Option exercise at $2.02 | $36,679 | |
Dec 10 2009 | NBY | Novabay Pharmaceuticals, Inc. | Tufts Robert R. | Director | 302 | Grant at $0.00 | $0 | |
Dec 10 2009 | NBY | Novabay Pharmaceuticals, Inc. | Dailley Anthony | Director | 302 | Grant at $0.00 | $0 | |
Dec 10 2009 | NBY | Novabay Pharmaceuticals, Inc. | McPherson T. Alex | Director | 603 | Grant at $0.00 | $0 | |
Oct 6 2009 | NBY | Novabay Pharmaceuticals, Inc. | Hixson Harry F Jr | Director | 343 | Grant at $0.00 | $0 | |
Oct 6 2009 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 343 | Grant at $0.00 | $0 | |
Oct 6 2009 | NBY | Novabay Pharmaceuticals, Inc. | McPherson T. Alex | Director | 686 | Grant at $0.00 | $0 | |
Oct 6 2009 | NBY | Novabay Pharmaceuticals, Inc. | Dailley Anthony | Director | 686 | Grant at $0.00 | $0 | |
Oct 6 2009 | NBY | Novabay Pharmaceuticals, Inc. | Tufts Robert R. | Director | 343 | Grant at $0.00 | $0 | |
Sep 15 2009 | NBY | Novabay Pharmaceuticals, Inc. | Hixson Harry F Jr | Director | 1,459 | Grant at $0.00 | $0 | |
Sep 14 2009 | NBY | Novabay Pharmaceuticals, Inc. | Hixson Harry F Jr | Director | 1,350 | Grant at $0.00 | $0 | |
Sep 14 2009 | NBY | Novabay Pharmaceuticals, Inc. | Tufts Robert R. | Director | 1,350 | Grant at $0.00 | $0 | |
Sep 14 2009 | NBY | Novabay Pharmaceuticals, Inc. | Wicks Tony D.S. | Director | 1,350 | Grant at $0.00 | $0 | |
Sep 14 2009 | NBY | Novabay Pharmaceuticals, Inc. | McPherson T. Alex | Director | 1,350 | Grant at $0.00 | $0 | |
Sep 14 2009 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 1,350 | Grant at $0.00 | $0 | |
Sep 14 2009 | NBY | Novabay Pharmaceuticals, Inc. | Dailley Anthony | Director | 1,350 | Grant at $0.00 | $0 | |
Sep 14 2009 | NBY | Novabay Pharmaceuticals, Inc. | Cashion Charles | Director | 1,350 | Grant at $0.00 | $0 | |
Sep 3 2009 | NBY | Novabay Pharmaceuticals, Inc. | Dailley Anthony | Director | 10,000 | Option exercise at $0.56 | $5,600 | |
Aug 31 2009 | NBY | Novabay Pharmaceuticals, Inc. | Tufts Robert R. | Director | 20,000 | Option exercise at $0.56 | $11,200 | |
Aug 31 2009 | NBY | Novabay Pharmaceuticals, Inc. | Cashion Charles | Director | 1,000 | Purchase at $1.90 | $1,900 | |
Aug 28 2009 | NBY | Novabay Pharmaceuticals, Inc. | Najafi Ramin | CEO | 1,000 | Purchase at $1.92 | $1,920 | |
Aug 28 2008 | NBY | Novabay Pharmaceuticals, Inc. | Najafi Ramin | CEO | 1,000 | Purchase at $1.92 | $1,920 | |
Aug 28 2009 | NBY | Novabay Pharmaceuticals, Inc. | Wicks Tony D.S. | Director | 1,428 | Grant at $0.00 | $0 | |
Aug 28 2009 | NBY | Novabay Pharmaceuticals, Inc. | Tufts Robert R. | Director | 1,428 | Grant at $0.00 | $0 | |
Aug 28 2009 | NBY | Novabay Pharmaceuticals, Inc. | McPherson T. Alex | Director | 1,428 | Grant at $0.00 | $0 | |
Aug 28 2009 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 1,428 | Grant at $0.00 | $0 | |
Aug 28 2009 | NBY | Novabay Pharmaceuticals, Inc. | Dailley Anthony | Director | 1,428 | Grant at $0.00 | $0 | |
Aug 28 2009 | NBY | Novabay Pharmaceuticals, Inc. | Cashion Charles | Director | 1,428 | Grant at $0.00 | $0 | |
Aug 13 2009 | NBY | Novabay Pharmaceuticals, Inc. | Tufts Robert R. | Director | 252 | Grant at $0.00 | $0 | |
Aug 13 2009 | NBY | Novabay Pharmaceuticals, Inc. | Hixson Harry F Jr | Director | 252 | Grant at $0.00 | $0 | |
Aug 13 2009 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 252 | Grant at $0.00 | $0 | |
Aug 13 2009 | NBY | Novabay Pharmaceuticals, Inc. | Cashion Charles | Director | 504 | Grant at $0.00 | $0 | |
Jun 11 2009 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 25,000 | Sale at $2.33 | $58,250 | |
Jun 11 2009 | NBY | Novabay Pharmaceuticals, Inc. | Hixson Harry F Jr | Director | 25,000 | Purchase at $2.33 | $58,250 | |
Jun 4 2009 | NBY | Novabay Pharmaceuticals, Inc. | Hixson Harry F Jr | Director | 1,369 | Grant at $0.00 | $0 | |
Jun 4 2009 | NBY | Novabay Pharmaceuticals, Inc. | McPherson T. Alex | Director | 1,618 | Grant at $0.00 | $0 | |
Jun 4 2009 | NBY | Novabay Pharmaceuticals, Inc. | Tufts Robert R. | Director | 1,369 | Grant at $0.00 | $0 | |
Jun 4 2009 | NBY | Novabay Pharmaceuticals, Inc. | Wicks Tony D.S. | Director | 1,618 | Grant at $0.00 | $0 | |
Jun 4 2009 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 1,369 | Grant at $0.00 | $0 | |
Jun 4 2009 | NBY | Novabay Pharmaceuticals, Inc. | Dailley Anthony | Director | 1,618 | Grant at $0.00 | $0 | |
Jun 4 2009 | NBY | Novabay Pharmaceuticals, Inc. | Cashion Charles | Director | 1,120 | Grant at $0.00 | $0 | |
May 14 2009 | NBY | Novabay Pharmaceuticals, Inc. | Tufts Robert R. | Director | 231 | Grant at $0.00 | $0 | |
May 14 2009 | NBY | Novabay Pharmaceuticals, Inc. | Hixson Harry F Jr | Director | 231 | Grant at $0.00 | $0 | |
May 14 2009 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 231 | Grant at $0.00 | $0 | |
May 14 2009 | NBY | Novabay Pharmaceuticals, Inc. | Cashion Charles | Director | 463 | Grant at $0.00 | $0 | |
May 7 2009 | NBY | Novabay Pharmaceuticals, Inc. | Hixson Harry F Jr | Director | 256 | Grant at $0.00 | $0 | |
May 7 2009 | NBY | Novabay Pharmaceuticals, Inc. | Tufts Robert R. | Director | 256 | Grant at $0.00 | $0 | |
May 7 2009 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 256 | Grant at $0.00 | $0 | |
May 7 2009 | NBY | Novabay Pharmaceuticals, Inc. | Cashion Charles | Director | 513 | Grant at $0.00 | $0 | |
Apr 24 2009 | NBY | Novabay Pharmaceuticals, Inc. | Dailley Anthony | Director | 220 | Grant at $0.00 | $0 | |
Apr 24 2009 | NBY | Novabay Pharmaceuticals, Inc. | Hixson Harry F Jr | Director | 220 | Grant at $0.00 | $0 | |
Apr 24 2009 | NBY | Novabay Pharmaceuticals, Inc. | Wicks Tony D.S. | Director | 440 | Grant at $0.00 | $0 | |
Mar 30 2009 | NBY | Novabay Pharmaceuticals, Inc. | Cashion Charles | Director | 472 | Grant at $0.00 | $0 | |
Mar 30 2009 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 236 | Grant at $0.00 | $0 | |
Mar 30 2009 | NBY | Novabay Pharmaceuticals, Inc. | Hixson Harry F Jr | Director | 236 | Grant at $0.00 | $0 | |
Mar 30 2009 | NBY | Novabay Pharmaceuticals, Inc. | Tufts Robert R. | Director | 236 | Grant at $0.00 | $0 | |
Mar 26 2009 | NBY | Novabay Pharmaceuticals, Inc. | Wicks Tony D.S. | Director | 1,357 | Grant at $0.00 | $0 | |
Mar 26 2009 | NBY | Novabay Pharmaceuticals, Inc. | Hixson Harry F Jr | Director | 1,357 | Grant at $0.00 | $0 | |
Mar 26 2009 | NBY | Novabay Pharmaceuticals, Inc. | Tufts Robert R. | Director | 1,357 | Grant at $0.00 | $0 | |
Mar 26 2009 | NBY | Novabay Pharmaceuticals, Inc. | McPherson T. Alex | Director | 1,357 | Grant at $0.00 | $0 | |
Mar 26 2009 | NBY | Novabay Pharmaceuticals, Inc. | Freiman Paul E. | Director | 1,357 | Grant at $0.00 | $0 |
D Derivative transaction exists
M Multiple transactions summarized; earliest reported transaction date and average weighted transaction price
Yahoo Finance